Histogenics (HSGX) News Today → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free HSGX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFeargal Sharkey: Desperate revival of failed policies doesn’t add upthetimes.co.uk - April 8 at 12:08 AMAspect Biosystems Appoints Three New Board Members - StreetInsider.comstreetinsider.com - September 21 at 6:25 PMAspect Biosystems Appoints Three New Board Members - Business Wirebusinesswire.com - September 21 at 1:25 PMAre Ocugen Or Amarin Good Stocks To Buy? - Investing.cominvesting.com - August 24 at 8:50 AM2022-08-05 | NDAQ:OCGN | Press Release | Ocugen, Inc. - Stockhousestockhouse.com - August 5 at 6:45 PMOcugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - GuruFocus.comgurufocus.com - June 23 at 8:39 AMOcugen Diversifies Its Pipeline With New Cell Therapy Platform By Benzinga - Investing.com UKuk.investing.com - May 25 at 3:24 AMOcugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - GlobeNewswireglobenewswire.com - May 25 at 3:24 AMOcugen (OCGN) Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition - StreetInsider.comstreetinsider.com - May 24 at 7:19 AMForm DEF 14A Aurinia Pharmaceuticals For: Apr 18 - StreetInsider.comstreetinsider.com - April 18 at 10:35 AMOcugen Is Two Strikes in With a Third in the Books - InvestorPlaceinvestorplace.com - March 8 at 2:31 PMCN.ORTH: New Blood on The Board - Yahoo Financenews.yahoo.com - October 26 at 10:26 PMGlobal Cell Therapy Market Outlook, Patent & Clinical Trials Report 2021-2028: Clinical & Commercial Insight On 32 Cell Therapies Available & Insight on 1600+ Cell Therapies in Clinical Trials - PRNewswireprnewswire.com - September 21 at 8:19 AMForm 8-K APPLIED GENETIC TECHNOLO For: Sep 08 - StreetInsider.comstreetinsider.com - September 8 at 3:49 PM Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address “Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. HSGX Media Mentions By Week HSGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HSGX News Sentiment▼0.000.38▲Average Medical News Sentiment HSGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HSGX Articles This Week▼00▲HSGX Articles Average Week Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INGN News Today COCH News Today CLGN News Today RBOT News Today MLSS News Today LFWD News Today SMTI News Today KNTE News Today SGMT News Today VXRT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HSGX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
